Panacea VC  ·  Research

Notes from the desk.

Perspectives on private markets, written for the desk’s investors and published here in full.

01
Investor Research Note  ·  July 2026

Beyond the AI Bubble

Our companies use AI. They do not sell it. That distinction is the whole of our exposure to an AI bubble.

02
Thematic Investment Note  ·  July 2026

The Biotech AI Valuation Gap

The market pays far more for AI applied to information than for AI applied to biology. We think that gap is an inefficiency, not a verdict.

03
Research Note · Thesis Update  ·  August 2026

The Biotech AI Inflection Point

We said the gap would narrow when biotech AI proved itself in the clinic. On 19 August, it did.

04
Company Thesis Note  ·  August 2026

Anthropic: Growth Is Real

The AI capital stack really is circular in places. Anthropic's revenue is not. Enterprises pay for the intelligence the compute produces.

05
Company Thesis Note  ·  September 2026

Revolut: From Disruptor to Global Bank

The investment case has shifted from customer acquisition to customer depth. Balances are growing more than twice as fast as customers.

These notes are for general informational purposes only and do not constitute investment advice or a recommendation regarding any specific security. Past performance and current market conditions are not indicative of future results. Investors should conduct independent due diligence and consult a licensed financial advisor before making investment decisions.